References
2019-nCoV Working Group. Communicable Diseases Network Australia.
Coronavirus Disease 2019 (COVID-19) CDNA National Guidelines for Public
Health Units 2020.
https://www1.health.gov.au/internet/main/publishing.nsf/Content/7A8654A8CB144F5FCA2584F8001F91E2/$File/COVID-19-SoNG-v3.10.pdf
(accessed November 8, 2020).
Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest
CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A
Report of 1014 Cases. Radiology 2020.
https://doi.org/10.1148/radiol.2020200642.
Alemany A, Baro B, Ouchi D, Ubals M, Corbacho-Monné M, Vergara-Alert J,
et al. Analytical and Clinical Performance of the Panbio COVID-19
Antigen-Detecting Rapid Diagnostic Test. MedRxiv
2020:2020.10.30.20223198. https://doi.org/10.1101/2020.10.30.20223198.
Amanat F, Stadlbauer D, Strohmeier S, Nguyen THO, Chromikova V, McMahon
M, et al. A serological assay to detect SARS-CoV-2 seroconversion in
humans. Nat Med 2020;26:1033–6.
https://doi.org/10.1038/s41591-020-0913-5.
Berry JD, Hay K, Rini JM, Yu M, Wang L, Plummer FA, et al. Neutralizing
epitopes of the SARS-CoV S-protein cluster independent of repertoire,
antigen structure or mAb technology. MAbs 2010;2:53–66.
Broughton JP, Deng X, Yu G, Fasching CL, Servellita V, Singh J, et al.
CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol
2020;38:870–4. https://doi.org/10.1038/s41587-020-0513-4.
CDC. Interim Guidance for Use of Pooling Procedures in SARS-CoV-2
Diagnostic, Screening, and Surveillance Testing. Cent Dis Control Prev
2020a.
https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling-procedures.html
(accessed November 10, 2020).
CDC. Information for Laboratories about Coronavirus (COVID-19). Cent Dis
Control Prev 2020b.
https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling-procedures.html
(accessed November 18, 2020).
CDC. Coronavirus Disease 2019 (COVID-19). Cent Dis Control Prev 2020c.
https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html
(accessed November 18, 2020).
Cherif A, Grobe N, Wang X, Kotanko P. Simulation of Pool Testing to
Identify Patients With Coronavirus Disease 2019 Under Conditions of
Limited Test Availability. JAMA Netw Open 2020;3.
https://doi.org/10.1001/jamanetworkopen.2020.13075.
Chi Q, Dai X, Jiang X, Zhu L, Du J, Chen Y, et al. Differential
diagnosis for suspected cases of coronavirus disease 2019: a
retrospective study. BMC Infect Dis 2020;20:679.
https://doi.org/10.1186/s12879-020-05383-y.
Deckert A, Bärnighausen T, Kyei NN. Simulation of pooled-sample analysis
strategies for COVID-19 mass testing. Bull World Health Organ
2020;98:590–8. https://doi.org/10.2471/BLT.20.257188.
Deeks J, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips
S, et al. Antibody tests for identification of current and past
infection with SARS‐CoV‐2. Cochrane Database Syst Rev 2020.
https://doi.org/10.1002/14651858.CD013652.
Diao B, Wen K, Chen Jian, Liu Y, Yuan Z, Han C, et al. Diagnosis of
Acute Respiratory Syndrome Coronavirus 2 Infection by Detection of
Nucleocapsid Protein. MedRxiv 2020:2020.03.07.20032524.
https://doi.org/10.1101/2020.03.07.20032524.
Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et
al. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis
of SARS‐CoV‐2 infection. Cochrane Database Syst Rev 2020.
https://www.readcube.com/articles/10.1002%2F14651858.CD013705 (accessed
November 12, 2020).
Food and Drug Administration USA. Coronavirus (COVID-19) Update FDA
Authorizes First Diagnostic Test for Screening of People Without Known
or [7256].pdf 2020.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-screening-people-without-known-or.
Güneyli S, Atçeken Z, Doğan H, Altınmakas E, Atasoy KÇ. Radiological
approach to COVID-19 pneumonia with an emphasis on chest CT. Diagn
Interv Radiol 2020;26:323–32. https://doi.org/10.5152/dir.2020.20260.
Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al. Profiling Early
Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin
Infect Dis 2020;71:778–85. https://doi.org/10.1093/cid/ciaa310.
Hanel R, Thurner S. Boosting test-efficiency by pooled testing for
SARS-CoV-2—Formula for optimal pool size. PLOS ONE 2020;15:e0240652.
https://doi.org/10.1371/journal.pone.0240652.
He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in
viral shedding and transmissibility of COVID-19. Nat Med 2020;26:672–5.
https://doi.org/10.1038/s41591-020-0869-5.
Hellou MM, Górska A, Mazzaferri F, Cremonini E, Gentilotti E, De Nardo
P, et al. Nucleic-acid-amplification tests from respiratory samples for
the diagnosis of coronavirus infections: systematic review and
meta-analysis. Clin Microbiol Infect 2020.
https://doi.org/10.1016/j.cmi.2020.11.002.
Jayamohan H, Lambert CJ, Sant HJ, Jafek A, Patel D, Feng H, et al.
SARS-CoV-2 pandemic: a review of molecular diagnostic tools including
sample collection and commercial response with associated advantages and
limitations. Anal Bioanal Chem 2020:1–23.
https://doi.org/10.1007/s00216-020-02958-1.
Ji T, Liu Z, Wang G, Guo X, Akbar khan S, Lai C, et al. Detection of
COVID-19: A review of the current literature and future perspectives.
Biosens Bioelectron 2020;166:112455.
https://doi.org/10.1016/j.bios.2020.112455.
Johns Hopkins Center for Health Security. Comparison of National RT-PCR
Primers, Probes, and Protocols for SARS-CoV-2 Diagnostics 2020.
https://www.centerforhealthsecurity.org/resources/COVID-19/COVID-19-fact-sheets/200410-RT-PCR.pdf
(accessed December 9, 2020).
Khalaf K, Papp N, Chou JT-T, Hana D, Mackiewicz A, Kaczmarek M.
SARS-CoV-2: Pathogenesis, and Advancements in Diagnostics and Treatment.
Front Immunol 2020;11. https://doi.org/10.3389/fimmu.2020.570927.
Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection
Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA
2020;323:2085–6. https://doi.org/10.1001/jama.2020.6266.
Kosack CS, Page A-L, Klatser PR. A guide to aid the selection of
diagnostic tests. Bull World Health Organ 2017;95:639–45.
https://doi.org/10.2471/BLT.16.187468.
Kubina R, Dziedzic A. Molecular and Serological Tests for COVID-19. A
Comparative Review of SARS-CoV-2 Coronavirus Laboratory and
Point-of-Care Diagnostics. Diagnostics 2020;10.
https://doi.org/10.3390/diagnostics10060434.
Lai CKC, Lam W. Laboratory testing for the diagnosis of COVID-19.
Biochem Biophys Res Commun 2020.
https://doi.org/10.1016/j.bbrc.2020.10.069.
Lippi G, Simundic A-M, Plebani M. Potential preanalytical and analytical
vulnerabilities in the laboratory diagnosis of coronavirus disease 2019
(COVID-19). Clin Chem Lab Med CCLM 2020;58:1070–6.
https://doi.org/10.1515/cclm-2020-0285.
Long Q-X, Liu B-Z, Deng H-J, Wu G-C, Deng K, Chen Y-K, et al. Antibody
responses to SARS-CoV-2 in patients with COVID-19. Nat Med
2020;26:845–8. https://doi.org/10.1038/s41591-020-0897-1.
Lorentzen HF, Schmidt SA, Sandholdt H, Benfield T. Estimation of the
diagnostic accuracy of real-time reverse transcription quantitative
polymerase chain reaction for SARS-CoV-2 using re-analysis of published
data. Dan Med J 2020;67.
Mallett S, Allen AJ, Graziadio S, Taylor SA, Sakai NS, Green K, et al.
At what times during infection is SARS-CoV-2 detectable and no longer
detectable using RT-PCR-based tests? A systematic review of individual
participant data. BMC Med 2020;18:346.
https://doi.org/10.1186/s12916-020-01810-8.
Pablos-Méndez A, Vega J, Aranguren FP, Tabish H, Raviglione MC. Covid-19
in Latin America. BMJ 2020;370. https://doi.org/10.1136/bmj.m2939.
Pan American Health Organization. Laboratory Guidelines for the
Detection and Diagnosis of COVID-19 Virus Infection - PAHO/WHO
| Pan American Health Organization 2020.
http://www.paho.org/en/documents/laboratory-guidelines-detection-and-diagnosis-covid-19-virus-infection
(accessed November 9, 2020).
Pan American Organization. PAHO Director says fight against COVID-19
pandemic must include chronic disease care - PAHO/WHO | Pan
American Health Organization 2020.
http://www.paho.org/en/news/26-5-2020-paho-director-says-fight-against-covid-19-pandemic-must-include-chronic-disease-care
(accessed November 8, 2020).
Rabe BA, Cepko C. SARS-CoV-2 detection using isothermal amplification
and a rapid, inexpensive protocol for sample inactivation and
purification. Proc Natl Acad Sci U S A 2020;117:24450–8.
https://doi.org/10.1073/pnas.2011221117.
Ravi N, Cortade DL, Ng E, Wang SX. Diagnostics for SARS-CoV-2 detection:
A comprehensive review of the FDA-EUA COVID-19 testing landscape.
Biosens Bioelectron 2020;165:112454.
https://doi.org/10.1016/j.bios.2020.112454.
Salameh J-P, Leeflang MM, Hooft L, Islam N, McGrath TA, Pol CB, et al.
Thoracic imaging tests for the diagnosis of COVID‐19. Cochrane Database
Syst Rev 2020. https://doi.org/10.1002/14651858.CD013639.pub2.
Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for
SARS-CoV-2. JAMA J Am Med Assoc 2020;323:2249.
Siam MdHB, Nishat NH, Ahmed A, Hossain MS. Stopping the COVID-19
Pandemic: A Review on the Advances of Diagnosis, Treatment, and Control
Measures. J Pathog 2020;2020. https://doi.org/10.1155/2020/9121429.
United Nations. Department of Healthcare Management and Occupational
Safety and Health. COVID-19: Differential Diagnosis and Co-infections
2020.
https://www.un.org/sites/un2.un.org/files/coronavirus_guidancecoinfections.pdf
(accessed November 22, 2020).
Virginia Department of Health. Antigen Testing Recommendations –
Coronavirus 2020.
https://www.vdh.virginia.gov/coronavirus/antigen-testing-recommendations/,
https://www.vdh.virginia.gov/coronavirus/antigen-testing-recommendations/
(accessed November 18, 2020).
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2
in Different Types of Clinical Specimens. JAMA 2020.
https://doi.org/10.1001/jama.2020.3786.
World Bank Development Indicators DataBank. n.d.
https://databank.worldbank.org/reports.aspx?source=2&series=SI.POV.GINI&country=
(accessed November 8, 2020).
World Health Organization. Diagnostic testing for SARS-CoV-2 2020a.
https://www.who.int/publications-detail-redirect/diagnostic-testing-for-sars-cov-2
(accessed November 8, 2020).
World Health Organization. Considerations for quarantine of contacts of
COVID-19 cases. WHO Interim Guidance. 2020b.
https://apps.who.int/iris/bitstream/handle/10665/333901/WHO-2019-nCoV-IHR_Quarantine-2020.3-eng.pdf?sequence=1&isAllowed=y
(accessed November 13, 2020).
World Health Organization. WHO COVID-19 Explorer n.d.
https://worldhealthorg.shinyapps.io/covid/ (accessed November 8, 2020).
World Health Organization (último). Antigen-detection in the diagnosis
of SARS-CoV-2 infection using rapid mmunoassays - Interim guidance 2020.
https://apps.who.int/iris/bitstream/handle/10665/334253/WHO-2019-nCoV-Antigen_Detection-2020.1-eng.pdf?sequence=1&isAllowed=y
(accessed November 17, 2020).
Zhu X, Ge Y, Wu T, Zhao K, Chen Y, Wu B, et al. Co-infection with
respiratory pathogens among COVID-2019 cases. Virus Res 2020;285:198005.
https://doi.org/10.1016/j.virusres.2020.198005.